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Aflatoxin M1 (AFM1) is a toxic metabolite of the fungal product aflatoxin found in milk. For
food safety concern, maximum residual limits of AFM1 in milk and dairy products have
been differently enforced in many countries. A suitable detection method is required to
screen a large number of product samples for the AFM1 contamination. In this study,
monoclonal antibodies (MAbs) against AFM1 were generated using a conventional somatic
cell fusion technique. After screening, five MAbs (AFM1-1, AFM1-3, AFM1-9, AFM1-11, and
AFM1-17) were obtained that showed cross-reactivity with aflatoxin B1 (AFB1) and aflatoxin
G1 (AFG1) but with no other tested compounds. An indirect competitive enzyme-linked
immunosorbent assay (ELISA) using a partially purified MAb and antigen-coated plates
yielded the best sensitivity with the 50% inhibition concentration (IC50) and the limit of
detection (LOD) values of 0.13 ng/mL and 0.04 ng/mL, respectively. This indirect competi-
tive ELISA was used to quantify the amount of fortified AFM1 in raw milk. The precision
and accuracy in terms of % coefficient of variation (CV) and % recovery of the detection was
investigated for both intra- (n ¼ 6) and inter- (n ¼ 12) variation assays. The % CV was found
in the range of 3.50e15.8% and 1.32e7.98%, respectively, while the % recovery was in the
range of 92e104% and 100e103%, respectively. In addition, the indirect ELISA was also used
to detect AFM1 fortified in processed milk samples. The % CV and % recovery values were
in the ranges of 0.1e33.0% and 91e109%, respectively. Comparison analysis between the
indirect ELISA and high performance liquid chromatography was also performed and
showed a good correlation with the R2 of 0.992 for the concentration of 0.2e5.0 ng/mL.
These results indicated that the developed MAb and ELISA could be used for detection of
AFM1 in milk samples.
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Aflatoxins (AFs) are a group of toxic substances produced by
the fungi Aspergillus flavus and Aspergillus parasiticus that grow
on corn, wheat, rice, peanuts, and dried fruits [1,2]. AFs are
considered genotoxins, teratogens, and immunosuppres-
sants, and also have antinutritional effects [3,4]. There are
four major types of aflatoxin: aflatoxin B1 (AFB1), aflatoxin B2
(AFB2), aflatoxin G1 (AFG1), and aflatoxin G2 (AFG2) (Figure 1).
These compounds are found in all animal feed preparation
steps. Upon ingestion by animals, they are transformed into
different metabolites with different levels of toxicity. Some
metabolites accumulate in the body, while others are excreted
via the urine, feces, or milk. The most toxic metabolite is 2, 3-
epoxside-AFB1, which binds to DNA and RNA, and may result
in liver cancer due to irregular protein synthesis [5,6]. In
addition to AFB1, another major concern is aflatoxin M1
(AFM1), which is secreted into the milk of lactating animals.
AFM1 can be found inmilk at ~0.5e5% of the ingested AFB1 [7].
It is stable under normal milk pasteurization and high-
temperature treatment [8,9]. AFM1 was also found in milk-
derived dairy products and importantly, in human breast
milk [7,10]. AFM1 is hepatotoxic and carcinogenic and is
classified as a Group 1 carcinogen by the International Agency
for Research on Cancer [2,11]. To reduce the risk of aflatox-
icosis, strict regulatory limits have been enforced in many
countries. In China and the USA, the maximum residue limit
(MRL) of AFM1 in milk is 0.5 ng/mL [12,13]. Moreover, in the
European Union, the MRL of AFM1 in rawmilk andmilk-based
products intended for adults is 0.05 ng/mL (European Com-
mission Regulation No. 1881/2006/EC). Therefore, the
contamination of AFM1 in milk products is under surveillance
in many countries to ensure product safety. Chemical-based
methods, such as fluorospectrophotometry, liquid chroma-
tography coupled with tandem mass spectrometry (LC-MS)
and high-performance liquid chromatography (HPLC), have
been used for AFM1 determination [14,15]. However, these
methods are relatively unsuitable for screening a largeFigure 1 e Chemical structure of major aflatoxins (A) AFB1; (Bnumber of samples compared with the immunological-based
methods, such as enzyme-linked immunosorbent assay
(ELISA) and immunochromatographic assay (ICA) or lateral
flow immunoassay (LFIA) [3]. LFIA is considered to be more
preferable than ELISA in terms of ease of use, short assay time,
and cost. But LFIA is often used qualitatively in tests that have
positive or negative results based on the cut off value. By
contrast, previous studies reported that ELISA can be used to
semiquantitatively detect drug residues in foods within the
acceptable ranges in terms of accuracy and precision [16e18].
In addition, if the antibody used in the ELISA is specific to
AFM1 as well as other aflatoxins such as AFB1 and AFG1 found
in foods and feeds, it might be more useful than LFIA, because
the regulated MRL values are different (0.5e300 ng/mL) for
different types of product. Use of LFIA with a specific cut off
value is limited to only a certain MRL value. A very high sen-
sitive LFIA with the cut off value or limit of detection of
0.02 mg/L which satisfies the EU maximum limit is not appli-
cable in the countries where the maximum limit is set at a
higher level such as 0.5 mg/L. For example, milk products
containing AFM1 at 0.1 mg/L would yield a positive result and
would be rejected by the LFIAwith the cut off value of 0.02 mg/L
although the AFM1 level of this sample is not higher than the
regulated limit of 0.5 mg/L. Therefore, ELISA is probably
preferred to LFIA for semiquantitative screening purpose. In
this study, monoclonal antibodies (MAbs) against AFM1 were
generated and used for the development of an antibody-
captured competitive indirect ELISA for AFM1 detection. The
reliability of the developed ELISA was also investigated.2. Methods
2.1. Materials, reagents, and animals
AFB1, AFG1, AFM1, and deoxynivalenol (DON) were purchased
from Fermentek (Jerusalem, Israel) with purity above 99%.
AFM1-BSA, bovine serum albumin (BSA), cinoxacin, cipro-
floxacin, enoxacin, enrofloxacin, Freund's complete adjuvant) AFB2; (C) AFG1; (D) AFG2; and (E) AFM1. AF ¼ aflatoxin.
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norfloxacin, oxytetracycline, 3, 30, 5, 50-tetramethylbenzidine
(TMB), tetracycline, and mouse MAb isotyping reagents were
purchased fromSigma-Aldrich (St. Louis, MO, USA). RPMI 1640
mediumwas purchased from Biochrom AG (Berlin, Germany).
Horseradish peroxidase-conjugates goat anti mouse immu-
noglobulin G (GAM-HRP) was purchased from Jackson
Immuno (West Grove, PA, USA). Myeloma cells P3-X63Ag8
were purchased from the American Type Culture Collection
(ATCC; TIB-9). Female (8-week-old) BALB/cmice (inbred strain)
were obtained from the National Laboratory Animal Centre,
Mahidol University, Nakhon Pathom, Thailand.
2.2. Production of hybridomas
Eight-week-old female BALB/C mice were immunized by
intraperitoneal injection with 100 mL of AFM1-BSA (2.5 mg/mL
AFM1-BSA dissolved in sterile phosphate buffer saline, PBS)
and an equal volume of FCA. Three booster doses of AFM1-
BSA in FIA at 2-week intervals were performed. One week
after the fourth injection, antiserum was collected and
checked for antibody titers by indirect ELISA. The final boost of
2.5 mg AFM1-BSA (without adjuvant) in sterilized normal saline
was performed. All procedures that involved animals were
approved by the Institutional Animal Care and Use Commit-
tee, the Institute of Biotechnology and Genetic Engineering,
Chulalongkorn University (Bangkok, Thailand; Protocol No.
1061001).
The generation of hybridomas was carried out using con-
ventional methods as described previously [19,20]. In brief,
isolated splenocytes were fused withmyeloma P3-X63Ag8 at a
cell ratio of 1:3 using 50% w/v polyethylene glycol (PEG) as the
fusion agent. Cells were suspended in 30 mL of RPMI 1640
medium containing 0.2 mg/mL gentamycin. The cell suspen-
sion was centrifuged at 380g for 5 minutes, and the cell pellet
was washed with the same medium to remove PEG. The hy-
bridomas were resuspended in hypoxanthineeaminopterine-
thymidine (HAT) selective medium supplement with 20% FCS
and distributed into 96-well tissue culture plates. The hy-
bridomas were cultured at 37C in a 5% CO2 incubator with a
suitable medium replacement interval. After 2 weeks, the
culture supernatants were screened for Abs against AFM1 by
an indirect ELISA. Positive cultures underwent single cell
cloning for multiple rounds by limiting dilution until mono-
clones were achieved.
2.3. ELISA
For indirect ELISA, 96-well plates were coated with 50 mL/well
of 1 mg/mL AFM1-BSA and incubated at 4C overnight. Plates
were washed three times with PBS containing 0.05% Tween 20
(PBST), blocked with 300 mL of 5% skimmed milk in PBS, and
incubated at 37C for 1 hour. After washing, the plates were
incubated with 100 mL/well of primary Ab (culture superna-
tants or antisera) for 2 hours, washed, and then incubated
with secondary Ab (0.8 mg/mL at 1:10,000 dilution GAM-HRP,
100 mL/well) at 37C for 1 hour. Enzyme assay was performed
using 0.0003% TMB in 0.2 M citrate buffer, pH 4.0 and 0.34%
H2O2 (100 mL/well) as the substrate. The reaction was allowed
to occur for 10 minutes and then stopped with 100 mL/well of1 M H2SO4. The absorbance at 450 nm was measured using a
microtiter plate reader.
For the indirect competitive ELISA, the protocol was the
same as that of the indirect ELISA with the exception that the
primary Ab was added together with the free AFM1 or the
competitors at the desired concentrations.2.4. Characterization of Ab
2.4.1. Free AFM1 binding ability of Ab
An indirect competitive ELISA was used to screen for Abs with
free AFM1 binding ability, which was determined by the %
competition using the following formula:
% Competition ¼ A450 without free AFM1A450 with free AFM1
A450 without free AFM1
 100
(1)
2.4.2. Sensitivity
The ELISA sensitivity was quantified based on the 50% inhi-
bition concentration (IC50), the concentration of the free AFM1
that resulted in a 50% reduction of the B/B0 ratio in which B is
the absorbance values obtained from the indirect competitive
ELISA at different concentrations of AFM1, and B0 is the
maximum absorbance when no competitor is present. In
addition to the IC50, limit of detection (LOD) was also used to
justify the sensitivity. The LOD was the AFM1 concentration
corresponding to the point at which the mean B0 value was
reduced by three times its standard deviation. Both the IC50
and the LOD values were analyzed using GraphPad Prism 4.03
software (GraphPad Software, Inc., CA, USA) from the plot of %
B/B0 versus AFM1 concentration.
2.4.3. Cross-reactivity
Cross-reactivity of the MAb was calculated using the ratio of
the standard AFM1 IC50 with the IC50 of the competitors using
the following formula:
% Cross-reactivity ¼ IC50 of AFM1
IC50 of competitor
 100 (2)
The IC50 values of the tested substances were obtained by
the indirect competitive ELISA as previously describedwith the
condition that the free AFM1 was replaced by the tested sub-
stances with varying concentration in the range of 0e4 mg/mL.2.5. Determination of AFM1 fortified in milk samples
Raw milk samples were fortified with AFM1 at a final con-
centration between 0 ng/mL and 0.8 ng/mL.Milk sampleswere
centrifuged at 3500g at 4C, and the upper fat layer was
removed (adapted from [21,22]). The fortified AFM1 concen-
trations were measured by indirect competitive ELISA. The
accuracy and precision of the analysis was evaluated by the %
recovery and % coefficient of variation (CV), respectively. The
analysis of six replicates of each dilution performed on 12
different lots was used to determine the intervariation of the
assays, while the analysis of those obtained on a single lot
were used to determine the intravariation of assays. The %
Figure 2 e Competitive inhibition curve of the obtained five
monoclonal antibodies applied in an indirect competitive
ELISA using 100 mL of 0.2 mg ml¡1 AFM1-BSA as the coating
antigen. In the assay, the culture supernatant of AFM1-9
was diluted at 1:1600 while those of other clones were
diluted at 1:3200. The assay was performed in triplicate.
AF ¼ aflatoxin; BSA ¼ bovine serum albumin;
ELISA ¼ enzyme-linked immunosorbent assay.
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formulas:
% Recovery ¼ 100  (measured concentration/fortified
concentration) (3)
% CV ¼ 100  (standard deviation/mean) (4)
In addition to raw milk, several commercially available
processed milks were also tested.
2.6. Comparative analysis between ELISA by HPLC
Milk samples were fortified with AFM1 at different concen-
trations between 0.2 ng/mL and 5.0 ng/mL and were compar-
atively analyzed using the developed ELISA and HPLC. HPLC
analysis was performed by the Central Laboratory Co., Ltd
(Bangkok, Thailand).3. Results and discussion
3.1. Generation of monoclonal antibody
AFM1 has a low molecular weight, and is a hapten molecule.
Therefore, it was coupled to a carrier protein, BSA, before
being used as an immunogen. After immunization four times
at 2-week intervals, antiserum from all mice was analyzed by
an indirect competitive ELISA to determine the antibody titer.
The titer was defined as the reciprocal of the antiserum dilu-
tion that results in an absorbance value that is twice the
background [23]. All mice responded to the immunization and
yielded a high antibody titer in the range of 1:8,192,000 and
1:32,768,000 (data not shown). Generally, an immunized
mouse suitable for further study should have an antibody titer
of at least 1:1000 [23]. The obtained antibodies could bind with
free AFM1 (data not shown), which is critical for use in an
ELISA. Five fusions between splenocytes and myeloma cell
lines yielded five monoclones, assigned as AFM1-1, AFM1-3,
AFM1-9, AFM1-15, and AFM1-17. Isotype of all obtained MAbs
was identified to be immunoglobulin G1 (data not shown).
3.2. Characterization of MAbs
Sensitivities of the obtained MAbs were quantified in terms of
IC50 and LOD by performing an indirect competitive ELISA.
The typical response curves of the five MAbs are shown in
Figure 2. The IC50 values were in a range of 0.02e0.04 ng/mL
while the LOD values were in a range of 0.01e0.02 ng/mL.
These results indicated that the obtained MAbs were suffi-
ciently sensitive to detect AFM1 when the current MRL value
was set at 0.5 ng/mL for raw milk and milk-based products.
However, among the five MAbs, the MAb from clone AFM1-9
was the most sensitive, with the lowest IC50 and LOD values.
In addition to sensitivity, specificity is also an important
characteristic of the MAb, and the % cross-reactivity (%CR) is
shown in Table 1. All the MAbs could bind to AFM1, as well as
AFB1 and AFG1. Surprisingly, the % CR of all the MAbs to AFB1and AFG1 was higher than those to AFM1 which was used as
the immunogen. This might be due to their similar structures.
The specificity of any Ab depends on the structure of the
immunogen and the ability of the immune response of the
individual immunized animal. In general, a small molecule
itself is not immunogenic and therefore, it must be conjugated
to a carrier protein and used as an immunogen. Aflatoxins are
considered to be a smallmolecule. Because theMAbs obtained
in this study showed strong cross-reactivity to AFM1, AFB1,
and AFG1, it is possible that these antibodies recognized the
same epitope in all aflatoxins. A polyclonal antibody against
AFM1 was produced using an AFM1-BSA conjugate as the
immunogen. The obtained antibody was specific to AFM1
(100%) and could bind to other aflatoxins to a lesser degree
(4%) [15]. In another study, MAbs were generated using an
AFM1-BSA conjugate [24]. The obtained MAbs were specific to
AFM1 and did not cross-react with AFB1, B2, G1 and G2. By
contrast, Zhang et al [25] produced Abs against AFB1, B2, G1,
and G2, but all five clones obtained produced Ab that cross-
reacted with AFM1. However, the ability of the anti-AFM1 Ab
to cross-react with other AFs is not a disadvantage because
AFM1 is only found in milk not contaminated with other AFs
[26]. Therefore, the detection of AFM1 in milk would not be
affected by these cross-reactivities. However, this is an
advantage in that the MAbs could be used to detect not only
AFM1 inmilk but also AFB1 and AFG1 which are usually found
in other food products and feeds. Importantly, the MAbs ob-
tained in this study did not cross-react to other tested myco-
toxin and antibiotics. This result indicated that theMAbswere
specific to aflatoxins.
3.3. Efficiency of AFM1 detection in raw milk by indirect
competitive ELISA
MAb AFM1-19 was partially purified and used in the newly
developed ELISA to determine the optimum concentration
ratio of the coating primary antibody to the horseradish
Table 1 e Cross-reactivity of the obtained MAb.
Competitors AFM1-1 AFM1-3 AFM1-9 AFM1-15 AFM1-17
IC50
(pg/mL)
CR
(%)
IC50
(pg/mL)
CR
(%)
IC50
(pg/mL)
CR
(%)
IC50
(pg/mL)
CR
(%)
IC50
(pg/mL)
CR
(%)
Aflatoxins
AFM1 40 100 36 100 17 100 18 100 22 100
AFB1 3 1328 2 1491 2 1043 1 3144 2 1393
AFG1 15 269 34 105 16 106 16 175 13 178
Mycotoxin
Deoxynivalenol >105 <0.04 >105 <0.04 >105 <0.02 >105 <0.03 >105 <0.02
Antibiotics
Tetracycline >105 <0.04 >105 <0.04 >105 <0.02 >105 <0.03 >105 <0.02
Oxytetracycline >105 <0.04 >105 <0.04 >105 <0.02 >105 <0.03 >105 <0.02
Chloramphenicol >105 <0.04 >105 <0.04 >105 <0.02 >105 <0.03 >105 <0.02
Ciprofloxacin >105 <0.04 >105 <0.04 >105 <0.02 >105 <0.03 >105 <0.02
Enrofloxacin >105 <0.04 >105 <0.04 >105 <0.02 >105 <0.03 >105 <0.02
Norfloxacin >105 <0.04 >105 <0.04 >105 <0.02 >105 <0.03 >105 <0.02
AF ¼ aflatoxin; CR ¼ cross-reactivity; IC50 ¼ 50% inhibition concentration; Mab ¼ monoclonal antibody.
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mized conditions, the IC50 and LOD values were 0.13 ng/mL
and 0.04 ng/mL, respectively (data not shown). Subsequently,
the indirect competitive ELISA was applied to detect AFM1
fortified in raw milk samples. The milk samples must be
centrifuged to separate the top lipid layer which can interfere
with ELISA and only the lower clear layer was used for ana-
lyses [7]. The percentages of recovery and the coefficient of
variation (CV) for both intra- and interassays are shown in
Table 2. The % recovery and % CV of the intra-assay were in
the range of 92e104% and 3.5e15.8%, while those of the
interassay were in the range of 100e103% and 1.32e7.98%,
respectively. Generally, the acceptable value of the % recovery
should be between 80% and 120% [27]. Therefore, these results
indicated that the accuracy and precision of the assay were
suitable for the detection of AFM1 in raw milk.
3.4. Analysis of AFM1 fortified in processed milk
products by indirect competitive ELISA
Different concentrations of AFM1 were fortified in various
processed milk samples and subsequently quantified by an
indirect competitive ELISA, as shown in Table 3. The accuracy
and precision of the assay were in an acceptable range whenTable 2 e Determination of AFM1 fortified in raw milk by indir
Fortified concentration (ng/ml) Intra-assay
Measured concentration
(ng mL1)
CV
(%)
0.80 0.83 ± 0.03 3.50
0.70 0.71 ± 0.05 6.82
0.60 0.62 ± 0.04 7.02
0.50 0.49 ± 0.08 15.8
0.40 0.40 ± 0.04 9.63
0.30 0.30 ± 0.01 4.47
0.20 0.18 ± 0.03 14.0
AF ¼ aflatoxin; CV ¼ coefficient of variation; ELISA ¼ enzyme-linked immpasteurized nonfat milk, sterilized nonfat milk, sterilized
milk, and powdered milk were used, with the exception of
powdered milk sample spiked at 0.2 ng/mL. AFM1 has a
melting point of approximately 299C, so it is relatively stable
under high temperatures; therefore, it cannot be destroyed by
either pasteurization or sterilization processes. Consequently,
milk products processed from raw milk contaminated with
AFM1 still contain AFM1 [13,18,28,29]. However, the assay
could not detect AFM1 spiked in all flavored milks, such as
pasteurized strawberry flavored milk and pasteurized choco-
late flavored milk (data not shown). This could be due to the
interference of the color of the additive flavor in the absor-
bance measurement. Samples diluted ~10e20 times after the
centrifugation step in the sample preparation could be used to
reduce the matrix effect of the sample [30]. However, the
sample should not be diluted in such a way that the AFM1
concentration is lower than the LOD value of the assay
method. In addition, immunomagnetic nanobeads (IMNB)
were recently employed in the sample preparation step for
AFM1 detection using a modified LFIA. AFM1 in the sample
was first captured by the IMNB and separated from the milk
matrix. The captured AFM1 was then eluted from the IMNB
and qualitatively detected by a conventional LFIA. This
resulted in improved detection sensitivity over a conventionalect competitive ELISA.
Inter-assay
Recovery (%) Measured concentration
(ng mL1)
CV
(%)
Recovery (%)
104 0.81 ± 0.01 1.32 101
102 0.71 ± 0.02 2.47 101
104 0.61 ± 0.01 1.86 102
97 0.51 ± 0.01 2.25 101
100 0.40 ± 0.01 3.51 101
100 0.30 ± 0.01 3.25 100
92 0.21 ± 0.02 7.98 103
unosorbent assay.
Table 3 e Determination of AFM1 fortified in some processed milk samples by indirect competitive ELISA.
Fortified concentration
(ng mL1)
Pasteurized nonfat milk Sterilized nonfat milk
Measured concentration
(ng mL1)
CV
(%)
Recovery
(%)
Measured concentration
(ng mL1)
CV
(%)
Recovery
(%)
0.80 0.73 ± 0.01 0.73 91 0.76 ± 0.01 0.60 95
0.70 0.66 ± 0.01 1.74 96 0.66 ± 0.02 2.40 94
0.60 0.57 ± 0.01 0.09 96 0.57 ± 0.01 2.20 95
0.50 0.50 ± 0.02 4.15 100 0.46 ± 0.01 2.10 92
0.40 0.42 ± 0.01 2.86 104 0.40 ± 0.02 4.40 100
0.30 0.31 ± 0.01 0.79 103 0.27 ± 0.03 11.9 90
0.20 0.19 ± 0.02 9.24 96 0.20 ± 0.02 11.3 100
Fortified concentration
(ng mL1)
Sterilized fresh milk Powdered milk
Measured concentration
(ng mL1)
CV
(%)
Recovery
(%)
Measured concentration
(ng mL1)
CV
(%)
Recovery
(%)
0.80 0.87 ± 0.01 0.10 109 0.82 ± 0.01 0.44 103
0.70 0.76 ± 0.01 0.35 108 0.71 ± 0.01 0.78 102
0.60 0.61 ± 0.01 1.55 102 0.59 ± 0.01 0.49 98
0.50 0.48 ± 0.01 1.94 96 0.52 ± 0.01 2.30 103
0.40 0.42 ± 0.01 3.53 105 0.41 ± 0.02 4.40 103
0.30 0.30 ± 0.02 5.37 101 0.30 ± 0.02 5.00 101
0.20 0.21 ± 0.01 5.97 103 0.20 ± 0.07 33.0 101
AF ¼ aflatoxin; CV ¼ coefficient of variation; ELISA ¼ enzyme-linked immunosorbent assay.
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times and 50 times, respectively [31]. However, only raw milk
samples were tested in this report. In addition, eight sterilized
unflavored milk samples from different producers were
collected from a local retail outlet in Bangkok, Thailand and
checked for AFM1 concentration. The test was also performed
using these samples spiked with AFM1 at 0.5 ng/mL as the
internal control. The AFM1 concentrations of nonspiked
samples were between 0 ng/mL and 0.14 ng/mL (Figure 3),
which is lower than the MRL of 0.5 ng/mL set by the United
States Food and Drug Administration but higher than the MRL
of 0.05 ng/mL enforced by the European Union for milk
products. However, several countries, including Thailand,
have not yet established regulatory limits for AFM1 [32,33].
These AFM1 concentrations were close to the highest con-
centration of 0.114 ng/mL determined from 150 pasteurized
milk samples from the School Milk Project in Thailand [32].
Consequently, there should be some caution in consuming
these milk and milk-based products.0.00
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Figure 3 e Detection of AFM1 in milk samples
commercially available in a local retail outlet. The assay
was performed in triplicate. AF ¼ aflatoxin.3.5. Comparison of AFM1 analysis between the
developed ELISA and HPLC
A sterilized milk sample was artificially contaminated with
AFM1 at different concentrations (between 0.02 ng/mL and
5.0 ng/mL). The AFM1 concentrations were then measured by
both the developed ELISA and HPLC as shown in Figure 4. A
linear regression analysis between both methods yielded a
good correlation with an R2 of 0.992. Moreover, a tendency of
bias deviation was not observed. This indicated that the
developed ELISA could be used to measure AFM1 in non-
colorized milk samples. This experiment was carried out
based on one milk sample fortified with AFM1 at various
concentrations and the reported amount of AFM1 at each
concentration was an average of six measurements. This
result could be used to observe a trend of analysis resultsy = 0.9354x + 0.0633
R² = 0.9925
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Figure 4 e Comparative measurement of AFM1 in milk
samples by the developed indirect competitive ELISA and
HPLC. AF ¼ aflatoxin; ELISA ¼ enzyme-linked
immunosorbent assay; HPLC ¼ high-performance liquid
chromatography.
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ysis at various AFM1 concentrations should be performed to
obtain more confident data. However, in general, ELISA was
intended to be used as a screening detection or semi-
quantitative method. The quantitative or confirmation
detection of AFM1 should be based on HPLC.
3.6. Conclusion
After conventional immunization and hybridoma cell prepa-
ration and screening, MAbs against AFM1 were generated.
These obtained antibodies could bind to AFM1 found in milk
as well as to AFB1 and AFG1 usually found in feeds and food
products. Using the optimized conditions, an indirect
competitive ELISA was employed to detect AFM1 fortified in
raw milk, unflavored pasteurized or sterilized milk samples
with a limit of detection of 0.2 ng/mL.Most of the accuracy and
precision of the assay were within an acceptable range.Conflicts of interest
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